SCHEMBL20900653

SCHEMBL20900653

CC(C)CCSc1ccc(-c2cnc(-c3ccc(C[C@H](NC(=O)c4ccc(C(C)(C)C)cc4)C(=O)NCCC(O)O)cc3)nc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CTSB P07858 3/20 0.40
▸ CTSS P25774 3/20 0.40
▸ CTSK P43235 3/20 0.40
▸ KIFC1 Q9BW19 6/20 0.38
▸ GCGR P47871 3/20 0.37
▸ ADCY6 O43306 1/20 0.37
▸ ADCY3 O60266 1/20 0.37
▸ ADCY9 O60503 1/20 0.37
▸ ADCY5 O95622 1/20 0.37
▸ ADCY8 P40145 1/20 0.37
▸ ADCY7 P51828 1/20 0.37
▸ ADCY2 Q08462 1/20 0.37
▸ ADCY1 Q08828 1/20 0.37
▸ ADCY4 Q8NFM4 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ CTSL P07711 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16305824 0.91 GCGR (0.47) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL20900666 0.84 PLG (0.48) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL22756229 0.83 L3MBTL1 (0.50) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL20900619 0.82 PLG (0.51) L3MBTL1KIFC1GCGRKLKB1
SCHEMBL19485577 0.82 KIFC1 (0.45) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL22384407 0.80 L3MBTL1 (0.45) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL16306220 0.79 GCGR (0.56) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL16305989 0.79 GCGR (0.47) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL22384055 0.79 L3MBTL1 (0.42) L3MBTL1CTSBCTSSCTSKKIFC1
SCHEMBL16305939 0.79 GCGR (0.48) L3MBTL1CTSBCTSSCTSKKIFC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10259823-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2019-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10259823-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR L3MBTL1 579/4885CTSB 1992/4885CTSS 3308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback